These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23378706)

  • 21. Ferulic acid 12% peel: An innovative peel for constitutional type of periorbital melanosis-Comparing clinical efficacy and safety with 20% glycolic peel and 15% lactic peel.
    Dayal S; Sangal B; Sahu P
    J Cosmet Dermatol; 2020 Sep; 19(9):2342-2348. PubMed ID: 31944519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Postinflammatory Hyperpigmentation With a Combination of Glycolic Acid Peels and a Topical Regimen in Dark-Skinned Patients: A Comparative Study.
    Sarkar R; Parmar NV; Kapoor S
    Dermatol Surg; 2017 Apr; 43(4):566-573. PubMed ID: 28114204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of combination of glycolic acid peeling with topical regimen in treatment of melasma.
    Chaudhary S; Dayal S
    J Drugs Dermatol; 2013 Oct; 12(10):1149-53. PubMed ID: 24085051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Efficacy of Chemical Peeling Agents in the Treatment of Melasma.
    Prasad N; Singh M; Malhotra S; Singh N; Tyagi A; Tyagi S
    Cureus; 2023 Oct; 15(10):e47312. PubMed ID: 38022044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: efficacy and improvement in quality of life.
    Dayal S; Sahu P; Dua R
    J Cosmet Dermatol; 2017 Mar; 16(1):35-42. PubMed ID: 27500896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal management of recalcitrant disorders of hyperpigmentation in dark-skinned patients.
    Stratigos AJ; Katsambas AD
    Am J Clin Dermatol; 2004; 5(3):161-8. PubMed ID: 15186195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness, safety, and effect on quality of life of topical salicylic acid peels for treatment of postinflammatory hyperpigmentation in dark skin.
    Joshi SS; Boone SL; Alam M; Yoo S; White L; Rademaker A; Helenowski I; West DP; Kundu RV
    Dermatol Surg; 2009 Apr; 35(4):638-44; discussion 644. PubMed ID: 19400885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence and considerations in the application of chemical peels in skin disorders and aesthetic resurfacing.
    Rendon MI; Berson DS; Cohen JL; Roberts WE; Starker I; Wang B
    J Clin Aesthet Dermatol; 2010 Jul; 3(7):32-43. PubMed ID: 20725555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study on fractional erbium glass laser therapy versus chemical peeling for the treatment of melasma in female patients.
    Puri N
    J Cutan Aesthet Surg; 2013 Jul; 6(3):148-51. PubMed ID: 24163531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years.
    Spierings NMK
    J Cosmet Dermatol; 2020 Jun; 19(6):1284-1289. PubMed ID: 31603285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The therapeutic value of glycolic acid peels in dermatology.
    Grover C; Reddu BS
    Indian J Dermatol Venereol Leprol; 2003; 69(2):148-50. PubMed ID: 17642863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melasma: an Up-to-Date Comprehensive Review.
    Ogbechie-Godec OA; Elbuluk N
    Dermatol Ther (Heidelb); 2017 Sep; 7(3):305-318. PubMed ID: 28726212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Deceptively Simple Solution for Refractory Melasma: Glycolic Acid Peels and Hydroquinone at Home.
    Mashiko T; Oka A; Osawa E; Koshima I
    Plast Reconstr Surg Glob Open; 2017 May; 5(5):e1335. PubMed ID: 28607861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of trichloroacetic acid versus glycolic acid chemical peels in the treatment of melasma.
    Kumari R; Thappa DM
    Indian J Dermatol Venereol Leprol; 2010; 76(4):447. PubMed ID: 20657143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Treatment Combination of Peels, Oral Antioxidants, and Topical Therapy for Refractory Melasma: A Report of 4 Cases.
    Piquero-Casals J; Granger C; Piquero-Casals V; Garre A; Mir-Bonafé JF
    Clin Cosmet Investig Dermatol; 2020; 13():209-213. PubMed ID: 32161485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newer and upcoming therapies for melasma.
    Sarkar R; Chugh S; Garg VK
    Indian J Dermatol Venereol Leprol; 2012; 78(4):417-28. PubMed ID: 22772611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Post-inflammatory hyperpigmentation occuring after cosmetic procedures].
    Beylot C; Raimbault-Gerard C
    Ann Dermatol Venereol; 2016 Dec; 143 Suppl 2():S33-S42. PubMed ID: 29452657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycolic acid peels versus amino fruit acid peels in the treatment of melasma.
    Ilknur T; Biçak MU; Demirtaşoğlu M; Ozkan S
    Dermatol Surg; 2010 Apr; 36(4):490-5. PubMed ID: 20187899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reflectance Confocal Microscopy Assessment of the Depigmenting Agents Complex for Melasma Treatment.
    Agozzino M; Licata G; Giorgio CMR; Babino G; Lupoli A; Sperduti I; Argenziano G; Ardigò M
    J Clin Aesthet Dermatol; 2020 Sep; 13(9):41-44. PubMed ID: 33133340
    [No Abstract]   [Full Text] [Related]  

  • 40. Ethnic considerations in the treatment of Hispanic and Latin-American patients with hyperpigmentation.
    Hexsel D; Arellano I; Rendon M
    Br J Dermatol; 2006 Dec; 156 Suppl 1():7-12. PubMed ID: 17176299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.